Related Experiment Video
Updated: Jul 19, 2025

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Glutamine metabolism in diseases associated with mitochondrial dysfunction.
Rebecca Bornstein1, Michael T Mulholland2, Margaret Sedensky3
1Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, USA.
Mitochondrial dysfunction disrupts glutamine metabolism, impacting brain cells and contributing to neurodegenerative diseases like Alzheimer's and Parkinson's. Targeting these pathways shows therapeutic promise.
Area of Science:
- Biochemistry
- Neuroscience
- Cell Biology
Background:
- Mitochondrial dysfunction, caused by genetic or environmental factors, affects numerous biological processes.
- Glutamine metabolism is crucial for cellular energy and communication, particularly in neurons and astrocytes.
- Altered glutamine metabolism is increasingly linked to the pathology of mitochondrial diseases and neurodegeneration.
Purpose of the Study:
- To review the intricate relationship between mitochondrial dysfunction and glutamine metabolism.
- To explore the role of glutamine metabolic alterations in neurodegenerative diseases.
- To identify potential therapeutic targets within glutamine metabolic pathways.
Main Methods:
- Literature review of studies on mitochondrial disease, glutamine metabolism, and neurodegeneration.
- Analysis of the impact of mitochondrial dysfunction on glutamine pathways.
- Examination of pharmacologic interventions in preclinical models.
Main Results:
- Mitochondrial dysfunction significantly alters glutamine consumption and catabolic flux.
- Aberrant glutamine metabolism is implicated in primary mitochondrial disorders (e.g., Leigh syndrome, MELAS) and age-related neurodegenerative diseases (e.g., Alzheimer's, Parkinson's).
- Preclinical studies suggest that targeting glutamine metabolism offers therapeutic benefits.
Conclusions:
- Glutamine metabolism is a critical mediator of mitochondrial dysfunction's impact on cellular health.
- Dysregulation of glutamine pathways is a key factor in neurodegeneration.
- Targeting glutamine metabolism represents a promising therapeutic strategy for mitochondrial and neurodegenerative diseases.
Related Concept Videos
Overview of Metabolism
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
Inorganic Nitrogen Assimilation
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Inborn Errors of Metabolism
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

